Advancing healthcare provider TB Testing

Responsive image

Register here to watch the webinar today!

Address1

Dummy field DO NOT USE/ DELETE/ MODIFY Needs to be hidden in CSS on LP

Referral source (URL)

Script on LP to collect URL

Instrument Type

If Opp Type is INSTRUMENT // For SP creation / could be hidden field

Buying Type

If Opp Type is INSTRUMENT // For SP creation / could be hidden field

Opportunity Type*

For SP creation / could be hidden field

Interaction Request*

For SP creation / could be hidden field

Lead Source - Most Recent*

For SP creation / could be hidden field

Primary Campaign Source*

For SP creation / could be hidden field

Specific Interest

Dr-Kawaruma-Webinar

Product Line Interest*

For SP creation / could be hidden field

BANT_Budget*

For SP creation / could be hidden field

BANT_Authority*

For SP creation / could be hidden field

BANT_Need*

For SP creation / could be hidden field

BANT_Time*

For SP creation / could be hidden field

First Name*

Last Name*

Company*

Email Address*

Job Position*

Phone*

City

Country*

State or Province

What test do you most often use as part of your clinical assessment for diagnosis of LTBI?*

Interferon-gamma release assay (IGRA): QuantiFERON®-TB Gold (Plus)

Interferon-gamma release assay (IGRA): T-SPOT®.TB

Tuberculin Skin Test (TST) / Mantoux

Not applicable

On average, how many TB tests does your practice perform a month?

I want to be the first to hear about offers and news from QIAGEN. *

I hereby give QIAGEN the consent to contact me via email and phone (subject to the contact information provided above) with further special offers, contests and product information.

Advancing healthcare provider TB Testing

The CDC recently released updated tuberculosis testing guidelines for healthcare providers (HCPs) in the US.

Join Dr. Masae Kawamura as she introduces the new national testing guidelines, the scientific rationale for change, and their implications for healthcare facilities and occupational health programs. She will also share the new evidence and advantages of QuantiFERON-TB Gold Plus (QFT-Plus) in HCP testing, in the context of the new guidelines and companion document. QFT-Plus is the most trusted test for HCP testing and most used IGRA in the US for risk-based testing and active TB contact investigations – which together form the backbone of the US TB prevention policies.

About the speaker: Masae Kawamura, M.D. Senior Director, Medical & Scientific Affairs - TB Diagnostics, QIAGEN.

QuantiFERON-TB Gold Plus (QFT-Plus) is an in vitro diagnostic aid for detection of Mycobacterium tuberculosis infection. QFT-Plus is an indirect test for M. tuberculosis infection (including disease) and is intended for use in conjunction with risk assessment, radiography, and other medical and diagnostic evaluations. QFT-Plus Package Inserts as well as up-to- date licensing information and product-specific disclaimers can be found at www.QuantiFERON.com.

+ Subject to your consent given above, QIAGEN may use your personal information for internal business and marketing purposes. The information will not be sold to any third party. QIAGEN may transfer your personal information to our CRM system (hosted by SalesForce.com, Inc. and Oracle Corp.) solely for the purposes of data hosting and QIAGEN email distribution. You may unsubscribe at any time. Your data will be processed in compliance with applicable privacy laws, including the EU General Data Protection Regulation. For further details, please refer to our Privacy Policy.